| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $53K | -73.8% |
| Cost of Revenue | $37K | +0.0% |
| Gross Profit | $53K | -67.9% |
| R&D Expense | $703 | -93.8% |
| SG&A Expense | $2.3M | +49.0% |
| Operating Income | -$2.2M | -63.1% |
| Pre-tax Income | -$2.3M | -66.2% |
| Net Income | -$2.3M | -66.2% |
| EPS (Basic) | -$0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204K | +0.0% |
| Accounts Receivable | $30K | -7.1% |
| Current Assets | $63K | -76.2% |
| Total Assets | $1.2M | +113.7% |
| Current Liabilities | $1.0M | +920.1% |
| Total Liabilities | $1.2M | +372.5% |
| Stockholders' Equity | -$17K | -105.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$805K | +28.9% |
| Investing Cash Flow | -$22K | +86.4% |
| Financing Cash Flow | $623K | -57.5% |
| -100.0% |
| EPS (Diluted) | -$0.02 | -100.0% |